TY - JOUR
T1 - Management of carotid artery stenosis
T2 - Comparing endarterectomy and stenting
AU - Hanel, Ricardo A.
AU - Xavier, Andrew R.
AU - Kirmani, Jawad F.
AU - Yahia, Abutaher M.
AU - Qureshi, Adnan I.
PY - 2003/3
Y1 - 2003/3
N2 - Stroke ranks as the third leading cause of death, behind diseases of the heart and cancer. It is also the most important cause of disability. Approximately 750,000 people experience a stroke annually, costing an estimated $40 billion in direct and indirect costs. Approximately 25% of these ischemic events are related to occlusive disease of the cervical internal carotid artery. Carotid atherovascular stenosis increases the risk of ischemic stroke by acting as an embolic source, and causing hypoperfusion of the ipsilateral cerebral hemisphere. With some limitations, the North American Symptomatic Carotid Endarterectomy Trial (NASCET), European Carotid Surgery Trialists' Collaborative Group (ECST), and Asymptomatic Carotid Atherosclerosis Study (ACAS) have shown that carotid endarterectomy (CEA) substantially reduces the risk of stroke associated with certain grades of carotid stenosis. During the past few years, carotid angioplasty and stenting (CAS) has evolved as an alternative to CEA, particulairly in patients who are known to have a higher complication rate with CEA.
AB - Stroke ranks as the third leading cause of death, behind diseases of the heart and cancer. It is also the most important cause of disability. Approximately 750,000 people experience a stroke annually, costing an estimated $40 billion in direct and indirect costs. Approximately 25% of these ischemic events are related to occlusive disease of the cervical internal carotid artery. Carotid atherovascular stenosis increases the risk of ischemic stroke by acting as an embolic source, and causing hypoperfusion of the ipsilateral cerebral hemisphere. With some limitations, the North American Symptomatic Carotid Endarterectomy Trial (NASCET), European Carotid Surgery Trialists' Collaborative Group (ECST), and Asymptomatic Carotid Atherosclerosis Study (ACAS) have shown that carotid endarterectomy (CEA) substantially reduces the risk of stroke associated with certain grades of carotid stenosis. During the past few years, carotid angioplasty and stenting (CAS) has evolved as an alternative to CEA, particulairly in patients who are known to have a higher complication rate with CEA.
UR - http://www.scopus.com/inward/record.url?scp=0037672849&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0037672849&partnerID=8YFLogxK
U2 - 10.1007/s11886-003-0084-2
DO - 10.1007/s11886-003-0084-2
M3 - Review article
C2 - 12583861
AN - SCOPUS:0037672849
VL - 5
SP - 153
EP - 159
JO - Current Cardiology Reports
JF - Current Cardiology Reports
SN - 1523-3782
IS - 2
ER -